The Chicken marker measures IgG antibodies to chicken proteins. Results are typically reported as none detected, very low, low, moderate, or high. These levels reflect immune exposure and recognition rather than a true food allergy. Interpreting the result alongside symptoms and dietary habits can help determine whether chicken may be contributing to delayed digestive or inflammatory symptoms.

Doctors recommend two doses of the chickenpox vaccine for children and unvaccinated individuals as the best protection against chickenpox, with most vaccinated people being protected for life. The vaccine is highly effective, preventing nearly all severe cases and resulting in milder symptoms for breakthrough cases. Children should receive doses at 12-15 months and 4-6 years, while older individuals should get two doses 28 days apart. Post-exposure vaccination can prevent or lessen the severity of the disease. Vaccination is crucial for at-risk groups like healthcare professionals, caregivers, and those in communal settings. Some individuals, such as those with immune system issues or who are pregnant, should consult a healthcare provider before getting vaccinated. The chickenpox vaccine is safe, effective, and has significantly reduced chickenpox cases, hospitalizations, and deaths since its introduction.

Chilomastix mesnili is a nonpathogenic flagellate that is often described as a commensal organism in the human gastrointestinal tract.

Chilomastix mesnili is a flagellated protozoan included in the Comprehensive Stool Analysis + Parasitology (CSAP) panel by Doctor's Data, which screens for a wide range of gastrointestinal pathogens. While typically considered a non-pathogenic commensal organism, its presence may indicate exposure to contaminated food or water and serves as a marker of fecal-oral transmission. Detection is reported using microscopy and may require multi-day stool collection due to intermittent shedding. Although it generally doesn't cause symptoms or require treatment, its presence should be interpreted in the context of other findings and patient symptoms to rule out co-infections or underlying GI issues.

The bacteria Chlamydia pneumoniae is spread by airborne droplets and infects the mucous membranes of the respiratory tract. These infections can be the cause of pharyngitis, laryngitis and sinusitis. A dry, hacking cough is the most common symptom of these infections. Not everyone who has mycoplasma and chlamydia in their nasopharynx gets sick - it depends on the body's resistance, but they can still infect others.

The bacteria Chlamydia pneumoniae is spread by airborne droplets and infects the mucous membranes of the respiratory tract. These infections can be the cause of pharyngitis, laryngitis and sinusitis. A dry, hacking cough is the most common symptom of these infections. Not everyone who has mycoplasma and chlamydia in their nasopharynx gets sick - it depends on the body's resistance, but they can still infect others.

The bacteria Chlamydia pneumoniae is spread by airborne droplets and infects the mucous membranes of the respiratory tract. These infections can be the cause of pharyngitis, laryngitis and sinusitis. A dry, hacking cough is the most common symptom of these infections. Not everyone who has mycoplasma and chlamydia in their nasopharynx gets sick - it depends on the body's resistance, but they can still infect others.

Chlamydia trachomatis is the most common cause of curable bacterial sexually transmitted infection (STI) worldwide. It manifests primarily as urethritis in males and endocervicitis in females.

Untreated chlamydial infection in man can cause epididymitis and proctitis. Though most women with Chlamydia infection are asymptomatic or have minimal symptoms, some develop salpingitis, endometritis, pelvic inflammatory disease (PID), ectopic pregnancy and tubal factor infertility. It is associated with an increased risk for the transmission or acquisition of HIV and is also attributed to be a risk factor for the development of cervical carcinoma.

Chlamydia, caused by the bacterium Chlamydia trachomatis, is one of the most prevalent sexually transmitted infections (STIs) worldwide. It primarily affects the genital tract, but can also impact the rectum, throat, and eyes. One of the key challenges in controlling Chlamydia is its often asymptomatic nature; a significant proportion of infected individuals exhibit no noticeable symptoms, thereby unknowingly facilitating its spread. When symptoms do occur, they can include genital discharge, burning during urination, lower abdominal pain, painful sexual intercourse for women, and testicular pain in men.

Chlamydias are obligate intracellular pathogens. Chlamydia pneumoniae (C. pneumoniae) is a human pathogen that infects the respiratory tract and is responsible for some cases of communityacquired pneumonia.

What is Chlamydophila pneumoniae – IgG?

Chlamydophila pneumoniae is a type of bacteria that commonly causes respiratory infections, including bronchitis, sinusitis, and atypical pneumonia. In most cases, infections are mild and self-limiting, but in some individuals—especially older adults or those with weakened immune systems—it can contribute to more persistent or chronic respiratory conditions.

The IgG antibody test for Chlamydophila pneumoniae measures the body’s long-term immune response to this bacterium. IgG antibodies usually appear several weeks after infection and can remain in the bloodstream for months or even years. This means an elevated IgG result indicates past exposure or a previous infection.

What Does a Medium Result Mean?

A medium IgG result reflects a moderate level of antibodies, which may indicate:

• A past infection that your body has responded to and is no longer fighting

• A waning or borderline immune response, depending on timing and overall health

• In some cases, cross-reactivity or residual antibodies from a remote infection

This result should be interpreted in the context of symptoms and additional lab findings.